News & Events
Featured
News
- Press ReleaseNovember 16, 2026
Goodwin Advises Pharmakon on Intellectual Property Aspects of $150 Million Loan for CorMedix
- Press ReleaseNovember 16, 2026
Goodwin Advises Royalty Pharma on Transactional and Intellectual Property Aspects of Royalty Stream Purchase From AstraZeneca
- Press ReleaseNovember 16, 2026
Goodwin Advises Alecto on $20 Million Seed Round
- Press ReleaseNovember 16, 2026
Goodwin Advises Calytrix Bio on Its Agreement To Be Acquired by Eli Lilly for up to $1.5 Billion
Events
- EventsNovember 10, 2026
Getting the Deal Done: Navigating M&A in a More Complex World
- EventsOctober 21, 2026
ChIPs Global Summit 2026
- Speaking EngagementsOctober 7, 2026
Computershare Industry Conference
- EventsOctober 7, 2026
Anderson v. Intel: Breaking Down the Supreme Court Argument on ERISA’s Duty of Prudence and the “Meaningful Benchmark” Requirement
Media Contact
Email
press@goodwinlaw.com
Phone
United States: +1 617 570 1500
Europe: +44 20 7447 4240
Asia: +852 3658 5305